ReviewMaterials today. Bio2025
3D bioprinted scaffolds for osteochondral regeneration: advancements and applications.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Engineering heterogeneous tissues and organs via multi-material bioprinting: Advances, challenges, and opportunities.Acta biomaterialia · 2026Review
- Innovative Hydroxyapatite-Hydrogel Composites for Cartilage Regeneration.Gels (Basel, Switzerland) · 2026Review
- Light-assisted 3D bioprinting of tough hydrogels in biomedical applications.Materials today. Bio · 2026Review
- Compressive stress-driven mechanosignaling in chondrocytes: From molecular mechanism to scaffold engineering and translational opportunities.Materials today. Bio · 2026Review
- BiomimeticBioactive materials · 2026Article
- Design Strategies to Target Joint Resident Mesenchymal Stem Cells for Osteochondral Regeneration.Cells · 2026Review
- Predicting Cell Differentiation in Mechanically Stimulated Biphasic Osteochondral Scaffolds Using Fluid-Structure Interaction Modelling.Bioengineering (Basel, Switzerland) · 2026Article
- Articular Cartilage Tissue Engineering: Cells, Bioinstructive Scaffolds, Immunological Microenvironment, and Emerging Technologies.Bioengineering (Basel, Switzerland) · 2026Review
- Natural Biomaterials for Osteochondral Repair: From Source to Strategy.Advanced healthcare materials · 2026Review
- From Nature to Innovation: Exploring Natural Biopolymers in 3D Bioprinting for Bone Regeneration.ACS omega · 2026Article
- 4D morphogenetic tissue engineering via gradient-crosslinked microporous hydrogel scaffolds.Materials today. Bio · 2026Article
- Advances in extrusion-based bioprinting enabled by advanced printhead and nozzle designs.Materials today. Bio · 2026Review
- Three-Dimensional Bioprinting and Rose-Inspired Medical Applications.Biomimetics (Basel, Switzerland) · 2026Review
- Advanced additive manufacturing in orthopedics: a comprehensive review of biomaterials, structural design, biological functions and clinical technology applications.RSC advances · 2026Review
- Kartogenin-loaded chitosan composite scaffold with cartilage-mimetic microstructure for layered osteochondral repair and cartilage phenotype maintenance.Materials today. Bio · 2026Article
- A multifunctional EGCG/Si nanohybrid-coated 3D-printed porous scaffold for bone defect repair.Regenerative biomaterials · 2026Article
- Review 3D-Printed hydrogels for tissue engineering: a review.Frontiers in bioengineering and biotechnology · 2026Review
- Neuro-immune-vascular-stem cell crosstalk in bone/cartilage regeneration: mechanisms, technological advances, and clinical perspectives.Frontiers in bioengineering and biotechnology · 2026Review
- 3D-bioprinting for joint regeneration.Frontiers in bioengineering and biotechnology · 2026Review
- Pathology-guided design of injectable hydrogels for precision therapy and cartilage regeneration in osteoarthritis.Regenerative biomaterials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteochondral defects, involving concurrent damage to articular cartilage and subchondral bone, pose significant clinical challenges due to their complex hierarchical structure and limited self-healing capacity. Traditional repair strategies often fail to replicate the biomechanical and biological gradients inherent to native osteochondral tissue, leading to suboptimal outcomes. Three-dimensional (3D) bioprinting has emerged as a transformative approach, enabling precise spatial deposition of biomaterials, cells, and signaling factors to construct biomimetic scaffolds with tailored gradients. This review systematically examines the physiological and pathological features of osteochondral units, emphasizing their zonal heterogeneity in extracellular matrix composition, mechanical properties, and cellular organization. Advancements in 3D bioprinting technologies are examined, and their efficacy in fabricating multi-layered and gradient scaffolds is evaluated. Key components of bioinks are discussed, focusing on optimizing bioink rheology, biocompatibility, and functional integration. Innovative strategies for embedding biochemical cues and designing continuous structural gradients are explored to address challenges in interfacial stress distribution and cell differentiation control. Furthermore, the design principles of biomimetic gradient scaffolds are highlighted for their critical role in facilitating osteochondral tissue regeneration. Finally, future directions are proposed, including high-resolution volumetric bioprinting, dynamic biomaterial development, and gene-activated scaffolds, aiming to bridge the gap between laboratory innovation and clinical application in osteochondral regeneration. This comprehensive analysis provides a roadmap for advancing 3D bioprinted solutions toward functional restoration of complex osteochondral defects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.